NYSE:RCOR

Renovacor (RCOR) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$3.20
$3.20
50-Day Range
$2.56
$3.28
52-Week Range
$1.34
$9.74
Volume
N/A
Average Volume
30,033 shs
Market Capitalization
$55.26 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
RCOR stock logo

About Renovacor Stock (NYSE:RCOR)

Renovacor, Inc., a biotechnology company, focuses on delivering various precision therapies to enhance the lives of patients and families battling genetically-driven cardiovascular and mechanistically-related diseases. It primarily focuses on the treatment of BCL2-associated athanogene 3 (BAG3) mutation-associated dilated cardiomyopathy (DCM). The company's lead product candidate is REN-001, a recombinant adeno-associated virus 9-based gene therapy designed to deliver a functional BAG3 gene to augment BAG3 protein levels in cardiomyocytes, and slow or halt progression of BAG3 DCM. It is also developing a pipeline of BAG3-associated gene therapies for diseases with high unmet medical need associated with mutations in the BAG3 gene and mechanistically linked to BAG3's expression and function. The company was founded in 2013 and is based in Greenwich, Connecticut.

RCOR Stock News Headlines

At first glance, this chart looks like nonsense…
We can isolate the most bullish dates to buy Netflix each and every year… That’s why one former hedge fund manager calls these dates… “Hotspot Dates”
At first glance, this chart looks like nonsense…
We can isolate the most bullish dates to buy Netflix each and every year… That’s why one former hedge fund manager calls these dates… “Hotspot Dates”
Robert W. Baird Keeps Their Hold Rating on Renovacor (RCOR)
Renovacor Announces Upcoming Presentation at...
See More Headlines
Receive RCOR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Renovacor and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/25/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
N/A
Fax
N/A
Employees
19
Year Founded
N/A

Profitability

Net Income
$-14,100,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$2.47 per share

Miscellaneous

Free Float
14,782,000
Market Cap
$55.26 million
Optionable
Not Optionable
Beta
-0.28
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

  • Dr. Magdalene K. Cook M.D.
    Chairman, Pres & CEO
  • Dr. Matthew Killeen Ph.D. (Age 39)
    Chief Scientific Officer
    Comp: $404.03k
  • Dr. Marc Semigran M.D. (Age 65)
    Chief Medical Officer
    Comp: $585.7k
  • Dr. Arthur Michael Feldman M.D.
    Ph.D., Founder & Member of Scientific Advisory Board
  • Ms. Wendy F. DiCicco CPA (Age 55)
    CPA, CFO & Principal Financial Officer
  • Dr. Elizabeth White Ph.D.
    Chief Bus. Officer & Sr. VP of Operations
  • Mr. Joseph Carroll
    Sr. VP, Chief Accounting Officer & Corp. Sec.
  • Dr. Jiwen Zhang Ph.D.
    Chief Regulatory Officer
  • Dr. Jordan Shin M.D.
    Ph.D., Sr. VP of Clinical Devel. & Translational Science
  • Dr. Kumar Dhanasekharan Ph.D.
    Sr. VP of Technical Operations

This page (NYSE:RCOR) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners